洛陽玻璃(600876.SH):桐城新能源太陽能裝備用光伏電池封裝材料一期項目點火投產
格隆匯3月29日丨洛陽玻璃(600876.SH)公佈,公司非公開發行股票募投項目之一“中國建材桐城新能源材料有限公司太陽能裝備用光伏電池封裝材料一期項目”主體工程順利完工,於2022年3月29日點火投產。
該項目的建成投產,有助於提升公司在光伏玻璃領域的行業地位,通過規模效應有效提升產品競爭力,推動公司新能源材料戰略目標的落地。該項目採用中建材蚌埠玻璃工業設計研究院有限公司自主開發的太陽能裝備用光伏電池封裝材料核心技術與成套裝備,產線規模處於行業前列。
該項目全面達產達標後,預計將對公司的生產經營帶來積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.